Ashler & Manson Logo

Ashler & Manson

ISIN

FR0012968485

Ticker

MLAEM

Sector

Financials

Sub-Industry

Insurance Brokers

Country

France

Year Founded

2003

About Ashler & Manson

Company Description

ASHLER & MANSON's teams are present in BORDEAUX (headquarters), NANTES, RENNES, PARIS, TOULOUSE, MARSEILLE, BIARRITZ and LYON. Our ambition is to become one of the leading French players in this market within the next five years.

The Group has more than 40 partnerships with the largest French and European banks and the main insurance companies. Some partnerships have been in place for more than 15 years.

The service provided by the brokers is now in line with what consumers expect:

- REACTIVITY and COMPETITIVENESS on credit offers by looking for the best rate and making the best credit offers of the moment available;

- INSURANCE solutions both in terms of cost and coverage thanks to the insurance brokerage offer allowing to divide the cost of the insurance up to three times in certain cases;

- ADVICE and ORGANISATION around the real estate project, becoming a real coach, the broker provides all the explanations to the end client to offer him a financing solution.

Served Area

France

Headquarters

2 Allée d'Orléans
33000, Bordeaux
France

Insider Trades

Date Trading entity / Person Association Trade type Volume
20.10.2023 None Other Buy EUR 1,600.00
22.09.2023 None Other Buy EUR 190.40
18.09.2023 None Other Buy EUR 3.40
11.09.2023 None Other Buy EUR 10.20
08.09.2023 None Other Buy EUR 3.40
24.08.2023 None Other Buy EUR 13.60
23.08.2023 None Other Buy EUR 326.40
16.08.2023 None Other Buy EUR 36.00
15.08.2023 None Other Buy EUR 1,886.40
04.08.2023 None Other Buy EUR 2,027.64

Capital Markets Information

ISIN

FR0012968485

LEI

969500NJJ5B6LG68FF12

Industry Group

Insurance

Industry

Insurance

Sub-Industry

Insurance Brokers

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.